5 completed, 2 recruiting, 1 terminated. 7 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 7 | Completed 5, Recruiting 2 |
| Phase 4 | 1 | Terminated 1 |
Follow Mastelli S.r.l: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Safety and Performance of the Medical Device RDM36 in the Treatment of Periodontal Gingival Contraction and in Black Triangles Syndrome (BTS) RDM36, Saline Solution (NaCl 0,9%) - Black Triangles Syndrome (BTS), Periodontal Gingival Contraction | Not applicable | Recruiting | Mastelli S.r.l | 40 | 2026-04-02 | 2026-05-12 |
| Clinical Investigation on a Polynucleotide-based Device Used to Improve Skin Hydration PN30 (RDM16) - Aesthetic Improvement of the Skin, Skin Hydration in Healthy Volunteers | Not applicable | Recruiting | Mastelli S.r.l | 43 | 2025-09-18 | 2026-02-03 |
| Efficacy and Safety of PN+HA (NEWEST) for the Improvement of Skin Hydration PN + HA (Newest) - Skin Hydration, Skin Elasticity | Not applicable | Completed | Mastelli S.r.l | 26 | 2024-12-18 | 2026-06-16 |
| Clinical Benefits and Safety of Tropho Tend in the Management of Painful Rotator Cuff Tendinopathy Polynucleotides (Tropho Tend), Rehabilitation physiotherapy - Rotator Cuff Tendinopathy | Not applicable | Completed | Mastelli S.r.l | 60 | 2024-12-10 | 2026-09-16 |
| Efficacy and Safety of PN20 (Plinest) for the Improvement of Skin Hydration PN20 (Plinest) - Skin Hydration, Skin Elasticity | Not applicable | Completed | Mastelli S.r.l | 25 | 2024-12-09 | 2026-06-16 |
| Clinical Benefits and Safety of Combined Polynucleotides and Hyaluronic Acid - Newest - for Acne Scars Treatment Subjects treated with Newest medical device - Atrophic Scar | Not applicable | Completed | Mastelli S.r.l | 30 | 2023-11-16 | 2025-08-12 |
| Study of Clinical Performance and Safety of Treatments in Degenerative Meniscopathy With Injection of Polynucleotides partial meniscectomy, Condrotide® (polynucleotides gel: class III medical device) - Meniscus Tear, Meniscus Lesion | Not applicable | Completed | Mastelli S.r.l | 60 | 2020-10-26 | 2025-08-12 |
| Efficacy and Safety of PLACENTEX ® i.m. in Patients With Scleroderma Diseases Polydeoxyribonucleotides - Scleroderma Disease | Phase 4 | Terminated | Mastelli S.r.l | 25 | 2016-11-08 | 2021-09-16 |
Facies (1) · Scleroderma, Diffuse (1) · Tendinopathy (1)
Polydeoxyribonucleotides (1) · Saline Solution (1)
Italy (8) · Belgium (1)
Elizaveta Kon, Prof. (1) · Emanuele Bartoletti, MD (1) · Peter Verdonk, Prof. (1) · Simona Muratori, Dr (1)
PMID 25224018, PMID 32799391, PMID 33755110, PMID 38371328, PMID 33480222